IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i1p523-d717115.html
   My bibliography  Save this article

Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review

Author

Listed:
  • Danielle Hen-Shoval

    (Psychology Department, Bar-Ilan University, Ramat Gan 5290002, Israel
    Gonda Brain Research Center, Bar-Ilan University, Ramat Gan 5290002, Israel)

  • Aron Weller

    (Psychology Department, Bar-Ilan University, Ramat Gan 5290002, Israel
    Gonda Brain Research Center, Bar-Ilan University, Ramat Gan 5290002, Israel)

  • Abraham Weizman

    (Geha Mental Health Center, Petah Tiqva 4910002, Israel
    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel)

  • Gal Shoval

    (Geha Mental Health Center, Petah Tiqva 4910002, Israel
    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel
    Princeton Neuroscience Institute, Princeton University, Princeton, NJ 08540, USA)

Abstract

Depression and anxiety disorders are two of the most common and growing mental health concerns in adolescents. Consequently, antidepressant medication (AD) use has increased widely during the last decades. Several classes of antidepressants are used mainly to treat depression, anxiety, and obsessive-compulsive disorders by targeting relevant brain neurochemical pathways. Almost all randomized clinical trials of antidepressants examined patients with no concomitant medications or drugs. This does not address the expected course of therapy and outcome in cannabis users. Cannabis is the most commonly used illicit substance globally. Substantial changes in its regulation are recently taking place. Many countries and US states are becoming more permissive towards its medical and recreational use. The psychological and physiological effects of cannabis (mainly of its major components, tetrahydrocannabinol (THC) and cannabidiol (CBD)) have been extensively characterized. Cannabis use can be a risk factor for depressive and anxiety symptoms, but some constituents or mixtures may have antidepressant and/or anxiolytic potential. The aim of this literature review is to explore whether simultaneous use of AD and cannabis in adolescence can affect AD treatment outcomes. Based on the current literature, it is reasonable to assume that antidepressants are less effective for adolescents with depression/anxiety who frequently use cannabis. The mechanisms of action of antidepressants and cannabis point to several similarities and conjunctions that merit future investigation regarding the potential effectiveness of antidepressants among adolescents who consume cannabis regularly.

Suggested Citation

  • Danielle Hen-Shoval & Aron Weller & Abraham Weizman & Gal Shoval, 2022. "Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review," IJERPH, MDPI, vol. 19(1), pages 1-19, January.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:1:p:523-:d:717115
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/1/523/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/1/523/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Öztürk, Gamze & Yetkiner, Hakan & Özden, Elif, 2020. "Macroeconomic determinants of antidepressant use," Journal of Policy Modeling, Elsevier, vol. 42(6), pages 1394-1407.
    2. Irving Kirsch & Brett J Deacon & Tania B Huedo-Medina & Alan Scoboria & Thomas J Moore & Blair T Johnson, 2008. "Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration," PLOS Medicine, Public Library of Science, vol. 5(2), pages 1-9, February.
    3. Giovanni Marsicano & Carsten T. Wotjak & Shahnaz C. Azad & Tiziana Bisogno & Gerhard Rammes & Maria Grazia Cascio & Heike Hermann & Jianrong Tang & Clementine Hofmann & Walter Zieglgänsberger & Vincen, 2002. "The endogenous cannabinoid system controls extinction of aversive memories," Nature, Nature, vol. 418(6897), pages 530-534, August.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Janus Christian Jakobsen & Jane Lindschou Hansen & Erik Simonsen & Christian Gluud, 2011. "The Effect of Interpersonal Psychotherapy and other Psychodynamic Therapies versus ‘Treatment as Usual’ in Patients with Major Depressive Disorder," PLOS ONE, Public Library of Science, vol. 6(4), pages 1-9, April.
    2. Michael A Sugarman & Amy M Loree & Boris B Baltes & Emily R Grekin & Irving Kirsch, 2014. "The Efficacy of Paroxetine and Placebo in Treating Anxiety and Depression: A Meta-Analysis of Change on the Hamilton Rating Scales," PLOS ONE, Public Library of Science, vol. 9(8), pages 1-15, August.
    3. Ad. J. W. van de Gevel & Charles N. Noussair, 2013. "The Nexus between Artificial Intelligence and Economics," SpringerBriefs in Economics, Springer, edition 127, number 978-3-642-33648-5, October.
    4. André Russowsky Brunoni & Mariana Lopes & Ted J Kaptchuk & Felipe Fregni, 2009. "Placebo Response of Non-Pharmacological and Pharmacological Trials in Major Depression: A Systematic Review and Meta-Analysis," PLOS ONE, Public Library of Science, vol. 4(3), pages 1-10, March.
    5. Weisz, George & Knaapen, Loes, 2009. "Diagnosing and treating premenstrual syndrome in five western nations," Social Science & Medicine, Elsevier, vol. 68(8), pages 1498-1505, April.
    6. Lijuan Guo & Zhaowei Kong & Yanjie Zhang, 2019. "Qigong-Based Therapy for Treating Adults with Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials," IJERPH, MDPI, vol. 16(5), pages 1-11, March.
    7. Felicity Thomas & Lorraine Hansford & Joseph Ford & Katrina Wyatt & Rosemarie McCabe & Richard Byng, 2018. "Moral narratives and mental health: rethinking understandings of distress and healthcare support in contexts of austerity and welfare reform," Palgrave Communications, Palgrave Macmillan, vol. 4(1), pages 1-8, December.
    8. Giuliano Masiero & Fabrizio Mazzonna & Sandro Steinbach & Olaf Verbeek, 2019. "The effect of local growth in antidepressant consumption on mental health outcomes," IdEP Economic Papers 1902, USI Università della Svizzera italiana.
    9. Giuliano Masiero & Fabrizio Mazzonna & Olaf Verbeek, 2018. "What drives the rise of antidepressant consumption? Evidence from Switzerland," IdEP Economic Papers 1801, USI Università della Svizzera italiana.
    10. Klaus Munkholm & Stephanie Winkelbeiner & Philipp Homan, 2020. "Individual response to antidepressants for depression in adults-a meta-analysis and simulation study," PLOS ONE, Public Library of Science, vol. 15(8), pages 1-16, August.
    11. Bütikofer, Aline & Cronin, Christopher J. & Skira, Meghan M., 2020. "Employment effects of healthcare policy: Evidence from the 2007 FDA black box warning on antidepressants," Journal of Health Economics, Elsevier, vol. 73(C).
    12. Lekeisha A. Sumner* & Waguih William IsHak & Jonathan Dang, MD & Brigitte Vanle & Naina Mahtani & Itai Danovitch, 2018. "Psychological Interventions in Inpatient Medical Settings: A Brief Review," International Journal of Healthcare and Medical Sciences, Academic Research Publishing Group, vol. 4(5), pages 73-83, 05-2018.
    13. William Hollingworth & Christopher G. Fawsitt & Padraig Dixon & Larisa Duffy & Ricardo Araya & Tim J. Peters & Howard Thom & Nicky J. Welton & Nicola Wiles & Glyn Lewis, 2020. "Cost-Effectiveness of Sertraline in Primary Care According to Initial Severity and Duration of Depressive Symptoms: Findings from the PANDA RCT," PharmacoEconomics - Open, Springer, vol. 4(3), pages 427-438, September.
    14. Juan Antonio Zarza-Rebollo & Esther Molina & Elena López-Isac & Ana M. Pérez-Gutiérrez & Blanca Gutiérrez & Jorge A. Cervilla & Margarita Rivera, 2022. "Interaction Effect between Physical Activity and the BDNF Val66Met Polymorphism on Depression in Women from the PISMA-ep Study," IJERPH, MDPI, vol. 19(4), pages 1-13, February.
    15. Bishop, Felicity L. & Jacobson, Eric E. & Shaw, Jessica R. & Kaptchuk, Ted J., 2012. "Scientific tools, fake treatments, or triggers for psychological healing: How clinical trial participants conceptualise placebos," Social Science & Medicine, Elsevier, vol. 74(5), pages 767-774.
    16. Janet M. Currie & W. Bentley MacLeod, 2018. "Understanding Doctor Decision Making: The Case of Depression," NBER Working Papers 24955, National Bureau of Economic Research, Inc.
    17. Petkova Eva & Tarpey Thaddeus & Govindarajulu Usha, 2009. "Predicting Potential Placebo Effect in Drug Treated Subjects," The International Journal of Biostatistics, De Gruyter, vol. 5(1), pages 1-27, July.
    18. Christopher Cronin & Matthew Forsstrom & Nicholas Papageorge, 2017. "Mental Health, Human Capital and Labor Market Outcomes," CINCH Working Paper Series 1704, Universitaet Duisburg-Essen, Competent in Competition and Health.
    19. Garret Christensen & Edward Miguel, 2018. "Transparency, Reproducibility, and the Credibility of Economics Research," Journal of Economic Literature, American Economic Association, vol. 56(3), pages 920-980, September.
    20. Emma Puighermanal & Marta Luna-Sánchez & Alejandro Gella & Gunter van der Walt & Andrea Urpi & María Royo & Paula Tena-Morraja & Isabella Appiah & Maria Helena de Donato & Fabien Menardy & Patrizia Bi, 2024. "Cannabidiol ameliorates mitochondrial disease via PPARγ activation in preclinical models," Nature Communications, Nature, vol. 15(1), pages 1-21, December.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:1:p:523-:d:717115. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.